(Liu Jingyi, a reporter from the Peoples Daily Health Client) Recently, "water flowers" in the synthetic biological field.On October 31, Hua Hao Zhongtian was listed on the Hong Kong Stock Exchange. This is the first pharmaceutical share that "synthetic creatures" ushered in after Hong Kong stocks welcomed the "first share of domestic self -exemptions" and "AI Pharmaceuticals" this year.Essence
Reporters from the Peoples Daily Health Client noticed that since the beginning of this year, the synthetic biological field has become a high -profile hot track, which has been favored by policies.Beijing, Anhui, Shaanxi and other places have issued relevant policies to support the development of synthetic biology, support the incremental biological industry, and promote the rise of the biological manufacturing industry with synthetic creatures.
On October 31, Hua Hao Zhongtian knocked on the bell on the Hong Kong Stock Exchange.Hua Hao Zhongtian Guan Weitu
More cities throw "high prices" support, Hangzhou released "Several Measures to Support the Synthetic Biological Industry"Funding for industrialization, characteristic parks, and public service platforms, up to 100 million yuan, and strive to achieve synthetic biological "research and development -conversion -industrial" coordinated development.
"Synthetic creatures are used as a biological manufacturing method. With the development of technology, its industry has covered many fields such as pharmaceutical manufacturing, medical beauty, and food. Synthetic biology is inThe pharmaceutical field can achieve more cost, higher purity, and safer biopharmaceutical production and development through the transformation of strains, such as new therapy for gene therapy and developing innovative drugs through AI.In an interview with the Peoples Daily Health Client, I said in an interview with the Peoples Daily.
In the capital market, the relevant concepts of synthetic biology are high, especially in May this year.Wind data shows that within 10 trading days from April 22 to May 8th, the Synthetic Biological Index rose continuously.Especially on May 8th, the broader market is under the background of weak adjustments. The synthetic biological sector has strengthened against the trend. The net inflow of funds throughout the day has become the concept sector with the largest amount of capital inflows that day.
On November 2nd, an investor in the field of pharmaceuticals told the Peoples Daily Health Client reporter that at present, some pioneer companies in this field have begun to show their sharp edge.With the continuous injection of a large amount of capital, synthetic biological companies will usher in more opportunities to promote technological innovation, market expansion and industrial upgrading."This trend has transformed the corporate technology research and development capabilities accordingly, and put forward new requirements."
